✦ LIBER ✦
Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib
✍ Scribed by Edwin Herrmann; Joachim Gerss; Stefan Bierer; Thomas Köpke; Christian Bolenz; Lothar Hertle; Christian Wülfing
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 315 KB
- Volume
- 135
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.